Metalloendoprotease Inhibitors Which Block the Differentiation of L6 Myoblasts Inhibit Insulin Degradation by the Endogenous Insulin-degrading Enzyme
Open Access
- 1 May 1989
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 264 (15) , 8928-8934
- https://doi.org/10.1016/s0021-9258(18)81882-8
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Metalloendoprotease inhibitors that block fusion also prevent biochemical differentiation in L6 myoblasts.Proceedings of the National Academy of Sciences, 1986
- Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease.Proceedings of the National Academy of Sciences, 1986
- Correlation between fusion and the developmental regulation of membrane glycoproteins in L6 myoblasts.Proceedings of the National Academy of Sciences, 1985
- Expression and amplification of the N-myc gene in primary retinoblastomaNature, 1984
- Rat myoblast fusion requires metalloendoprotease activityCell, 1983
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Inhibition of thermolysin and carboxypeptidase A by phosphoramidatesBiochemistry, 1979
- Active site directed irreversible inhibition of thermolysinBiochemistry, 1978
- Studies on inhibitory effect of phosphoramidon and its analogs on thermolysinArchives of Biochemistry and Biophysics, 1975
- A THERMOLYSIN INHIBITOR PRODUCED BY ACTINOMYCETES: PHOSPHORAMIDONThe Journal of Antibiotics, 1973